Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies

被引：14

作者：

Ambrosini, Giulia ^{[1
]}

Cordani, Marco ^{[2
,3
]}

Zarrabi, Ali ^{[4
,5
]}

Alcon-Rodriguez, Sergio ^{[6
,7
,8
]}

Sainz, Rosa M. ^{[6
,7
,8
]}

Velasco, Guillermo ^{[2
,3
]}

Gonzalez-Menendez, Pedro ^{[6
,7
,8
]}

Dando, Ilaria ^{[1
]}

机构：

[1] Univ Verona, Dept Neurosci Biomed & Movement Sci, I-37134 Verona, Italy

[2] Univ Complutense Madrid, Fac Biol, Dept Biochem & Mol Biol, Madrid 28040, Spain

[3] Inst Invest Sanit San Carlos IdISSC, Madrid 28040, Spain

[4] Istinye Univ, Fac Engn & Nat Sci, Dept Biomed Engn, TR-34396 Istanbul, Turkiye

[5] Saveetha Univ, Saveetha Dent Coll & Hosp, Saveetha Inst Med & Tech Sci, Dept Res Analyt, Chennai 600077, India

[6] Sch Med, Dept Morfol & Biol Celular, Julian Claveria 6, Oviedo 33006, Spain

[7] Univ Oviedo, Inst Univ Oncol Principado Asturias IUOPA, Oviedo 33006, Spain

[8] Hosp Univ Cent Asturias HUCA, Inst Invest Sanit Principado Asturias ISPA, Oviedo 33011, Spain

来源：

CELL COMMUNICATION AND SIGNALING | 2024年 / 22卷 / 01期

关键词：

Prostate cancer; Oncometabolites; Epigenetic alterations; Cancer stem cells (CSCs); Metabolic Enzymes; EMT; EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN SEMINAL FLUID; ANDROGEN RECEPTOR; TGF-BETA; STROMAL FIBROBLASTS; SUPPRESSOR-CELLS; REACTIVE STROMA; GENE-EXPRESSION; GROWTH; METABOLISM;

D O I：

10.1186/s12964-023-01462-0

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Prostate cancer, as one of the most prevalent malignancies in males, exhibits an approximate 5-year survival rate of 95% in advanced stages. A myriad of molecular events and mutations, including the accumulation of oncometabolites, underpin the genesis and progression of this cancer type. Despite growing research demonstrating the pivotal role of oncometabolites in supporting various cancers, including prostate cancer, the root causes of their accumulation, especially in the absence of enzymatic mutations, remain elusive. Consequently, identifying a tangible therapeutic target poses a formidable challenge. In this review, we aim to delve deeper into the implications of oncometabolite accumulation in prostate cancer. We center our focus on the consequential epigenetic alterations and impacts on cancer stem cells, with the ultimate goal of outlining novel therapeutic strategies.

引用

页数：22

共 209 条

[11] Ketones and lactate "fuel" tumor growth and metastasis Evidence that epithelial cancer cells use oxidative mitochondrial metabolism [J].

Bonuccelli, Gloria ;

Tsirigos, Aristotelis ;

Whitaker-Menezes, Diana ;

Pavlides, Stephanos ;

Pestell, Richard G. ;

Chiavarina, Barbara ;

Frank, Philippe G. ;

Flomenberg, Neal ;

Howell, Anthony ;

Martinez-Outschoorn, Ubaldo E. ;

Sotgia, Federica ;

Lisanti, Michael P. .

CELL CYCLE, 2010, 9 (17) :3506-3514

[12] Expression of Cationic Amino Acid Transporter 2 Is Required for Myeloid-Derived Suppressor Cell-Mediated Control of T Cell Immunity [J].

Bozkus, Cansu Cimen ;

Elzey, Bennett D. ;

Crist, Scott A. ;

Ellies, Lesley G. ;

Ratliff, Timothy L. .

JOURNAL OF IMMUNOLOGY, 2015, 195 (11) :5237-5250

[13] Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers [J].

Bronte, V ;

Kasic, T ;

Gri, G ;

Gallana, K ;

Borsellino, G ;

Marigo, I ;

Battistini, L ;

Iafrate, M ;

Prayer-Galetti, T ;

Pagano, F ;

Viola, A .

JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (08) :1257-1268

[14] Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors [J].

Butler, Jason M. ;

Kobayashi, Hideki ;

Rafii, Shahin .

NATURE REVIEWS CANCER, 2010, 10 (02) :138-146

[15] Mechanisms of resistance in castration-resistant prostate cancer (CRPC) [J].

Chandrasekar, Thenappan ;

Yang, Joy C. ;

Gao, Allen C. ;

Evans, Christopher P. .

TRANSLATIONAL ANDROLOGY AND UROLOGY, 2015, 4 (03) :365-380

[16] Hedgehog overexpression leads to the formation of prostate cancer stem cells with metastatic property irrespective of androgen receptor expression in the mouse model [J].

Chang, Han-Hsin ;

Chen, Bo-Yie ;

Wu, Chia-Yung ;

Tsao, Zih-Jay ;

Chen, Ying-Yu ;

Chang, Chin-Pao ;

Yang, Chi-Rei ;

Lin, David Pei-Cheng .

JOURNAL OF BIOMEDICAL SCIENCE, 2011, 18

[17] Reversal of Lactate and PD-1-mediated Macrophage Immunosuppression Controls Growth of PTEN/p53-deficient Prostate Cancer [J].

Chaudagar, Kiranj ;

Hieromnimon, Hanna M. ;

Khurana, Rimpi ;

Labadie, Brian ;

Hirz, Taghreed ;

Mei, Shenglin ;

Hasan, Raisa ;

Shafran, Jordan ;

Kelley, Anne ;

Apostolov, Eva ;

Al-Eryani, Ghamdan ;

Harvey, Kate ;

Rameshbabu, Srikrishnan ;

Loyd, Mayme ;

Bynoe, Kaela ;

Drovetsky, Catherine ;

Solanki, Ani ;

Markiewicz, Erica ;

Zamora, Marta ;

Fan, Xiaobin ;

Schuer, Stephan ;

Swarbrick, Alex ;

Sykes, David B. ;

Patnaik, Akash .

CLINICAL CANCER RESEARCH, 2023, 29 (10) :1952-1968

[18] Epithelial-Mesenchymal Transition Signaling and Prostate Cancer Stem Cells: Emerging Biomarkers and Opportunities for Precision Therapeutics [J].

Chaves, Luiz Paulo ;

Melo, Camila Morais ;

Saggioro, Fabiano Pinto ;

Reis, Rodolfo Borges dos ;

Squire, Jeremy Andrew .

GENES, 2021, 12 (12)

[19] Lactylation, a Novel Metabolic Reprogramming Code: Current Status and Prospects [J].

Chen, An-Na ;

Luo, Yan ;

Yang, Yu-Han ;

Fu, Jian-Tao ;

Geng, Xiu-Mei ;

Shi, Jun-Ping ;

Yang, Jin .

FRONTIERS IN IMMUNOLOGY, 2021, 12

[20] CNTN-1 promotes docetaxel resistance and epithelial-to-mesenchymal transition via the PI3K/Akt signaling pathway in prostate cancer [J].

Chen, Binshen ;

Zhang, Yiming ;

Li, Chaoming ;

Xu, Peng ;

Gao, Yubo ;

Xu, Yawen .

ARCHIVES OF MEDICAL SCIENCE, 2021, 17 (01) :152-165

← 1 2 3 4 5 6 7 8 9 10 →